DSpace@İnönü

Yazar "Hacibekiroglu, I" için Araştırma Çıktıları | Pubmed İndeksli Yayınlar Koleksiyonu listeleme

Yazar "Hacibekiroglu, I" için Araştırma Çıktıları | Pubmed İndeksli Yayınlar Koleksiyonu listeleme

Sırala: Sıra: Sonuçlar:

  • Evaluation of prognostic factors in localized high-grade 
    Ozcelik, M; Seker, M; Eraslan, E; Koca, S; Yazilitas, D; Ercelep, O; Ozaslan, E; Kaya, S; Hacibekiroglu, I; Menekse, S; Aksoy, A; Taskoylu, BY; Varol, U; Arpaci, E; Ciltas, A; Oksuzoglu, B; Zengin, N; Gumus, M; Aliustaoglu, M (2016)
    Most data on prognostic factors for patients with high-grade undifferentiated pleomorphic sarcoma (HGUPS) is obtained from analyses of soft tissue sarcomas. The purpose of this study was to evaluate the clinicopathologic ...
  • The effect of the gastrectomy on survival in patients with metastatic 
    Yazici, O; Ozdemir, N; Duran, AO; Menekse, S; Ali, M; Sendur, N; Karaca, H; Goksel, G; Arpaci, E; Hacibekiroglu, I; Bilgetekin, I; Kacan, T; Ozkan, M; Aksoy, S; Aksoy, A; Cokmert, S; Uysal, M; Elkiran, ET; Cicin, I; Buyukberber, S; Zengin, N (2016)
    Aim: To investigate the role of surgical resection of primary tumor on overall survival (OS) in advanced gastric cancer patients at the time of diagnosis. Patients & methods: The survival rates of metastatic gastric cancer ...
  • Evaluation of prognostic factors in localized high-grade 
    Ozcelik, M; Seker, M; Eraslan, E; Koca, S; Yazilitas, D; Ercelep, O; Ozaslan, E; Kaya, S; Hacibekiroglu, I; Menekse, S; Aksoy, A; Taskoylu, BY; Varol, U; Arpaci, E; Ciltas, A; Oksuzoglu, B; Zengin, N; Gumus, M; Aliustaoglu, M (2016)
    Most data on prognostic factors for patients with high-grade undifferentiated pleomorphic sarcoma (HGUPS) is obtained from analyses of soft tissue sarcomas. The purpose of this study was to evaluate the clinicopathologic ...
  • Prognostic factors of patients who received chemotherapy after cranial 
    Inal, A; Kodaz, H; Odabas, H; Duran, AO; Seker, MM; Inanc, M; Elkiran, ET; Gunaydin, Y; Menekse, S; Topcu, TO; Urakci, Z; Tastekin, D; Bilici, M; Cihan, S; Geredeli, C; Sezer, E; Uncu, D; Arpaci, E; Ozturk, B; Bal, O; Uysal, M; Tanriverdi, O; Gumus, M; Ustaalioglu, BBO; Suner, A; Cokmert, S; Hacibekiroglu, I; Aydin, K; Isikdogan, A (2018)
    Purpose: Almost half of all patients diagnosed with non-small cell lung cancer (NSCLC) have distant metastases at presentation. One-third of patients with NSCLC will have brain metastases. Without effective treatment, the ...
  • Prognostic factors of patients who received chemotherapy after cranial 
    Inal, A; Kodaz, H; Odabas, H; Duran, AO; Seker, MM; Inanc, M; Elkiran, ET; Gunaydin, Y; Menekse, S; Topcu, TO; Urakci, Z; Tastekin, D; Bilici, M; Cihan, S; Geredeli, C; Sezer, E; Uncu, D; Arpaci, E; Ozturk, B; Bal, O; Uysal, M; Tanriverdi, O; Gumus, M; Ustaalioglu, BBO; Suner, A; Cokmert, S; Hacibekiroglu, I; Aydin, K; Isikdogan, A (2018)
    Purpose: Almost half of all patients diagnosed with non-small cell lung cancer (NSCLC) have distant metastases at presentation. One-third of patients with NSCLC will have brain metastases. Without effective treatment, the ...
  • The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab 
    Ozdemir, O; Zengel, B; Yildiz, Y; Uluc, BO; Cabuk, D; Ozden, E; Salim, DK; Paydas, S; Demir, A; Diker, O; Pilanci, KN; Sonmez, OU; Vatansever, S; Dogan, I; Gulmez, A; Cakar, B; Gursoy, P; Yildirim, ME; Ayhan, M; Karadurmus, N; Aykan, MB; Cevik, GT; Sakalar, T; Hacibekiroglu, I; Gulbagci, BB; Dincer, M; Garbioglu, DB; Kemal, Y; Nayir, E; Taskaynatan, H; Yilmaz, M; Avci, O; Sari, M; Coban, E; Atci, MM; Esen, SA; Telli, TA; Karatas, F; Inal, A; Demir, H; Kalkan, NO; Yilmaz, C; Tasli, F; Alacacioglu, A (2022)
    In our study, we aimed to evaluate the pathological response rates and side effect profile of adding pertuzumab to the treatment of HER2+ locally advanced, inflammatory, or early-stage breast cancer. This study was conducted ...
  • Real life experience of patients with locally advanced gastric and 
    Basoglu, T; Sakin, A; Erol, C; Ozden, E; Cabuk, D; Cilbir, E; Ozyukseler, DT; Ayhan, M; Sendur, MA; Dogan, M; Oksuzoglu, B; Eryilmaz, MK; Er, O; Tasci, ES; Ozyurt, N; Dulgar, O; Ozen, M; Hacibekiroglu, I; Oner, I; Bekmez, ET; Yildirim, HC; Yalcin, S; Paydas, S; Yekeduz, E; Aksoy, A; Ozcelik, M; Oyman, A; Almuradova, E; Karabulut, B; Demir, N; Dincer, M; Ozdemir, N; Erdem, D; Ak, N; Inal, A; Salim, DK; Deniz, GI; Sakalar, T; Gulmez, A; Kacan, T; Ozdemir, O; Alan, O; Unal, C; Karakas, Y; Turhal, S; Yumuk, PF
    Neoadjuvant chemotherapy (NACT) in gastroesophageal junction (GEJ) and gastric cancer (GC) was shown to improve survival in recent studies. We aimed to share our real-life experience of patients who received NACT to compare ...